ANALYSIS OF THE ACTIVE PHARMACEUTICAL INGREDIENTS ASSORTMENT REGISTERED ON UKRAINE MARKET
DOI:
https://doi.org/10.11603/2312-0967.2020.3.11429Keywords:
active pharmaceutical ingredients, pharmaceutical market of Ukraine, assortment (range, value)Abstract
The aim of the work. To analyze and structure the registered on market of Ukraine active pharmaceutical ingredients assortment.
Materials and Methods. Methods of content analysis, structuring, comparative and graphical generalization of data from the State Register of Medicines and pharmaceutical inserts were applied.
Results and Discussion. 2100 trade names of active pharmaceutical ingredients, that are manufactured in 51 countries, are registered on pharmaceutical market of Ukraine. It is established that the level of domestic ones is over 16 %, 1/5 of their total number is manufactured on JSC “Liktravy” (medicinal plant raw materials). Indian companies predominate among foreign manufacturers (29.1 %). The leaders are Hetero Drugs Limited (5.9 %) and Hetero Labs Limited (5.5 %) companies.
The absence of domestic active pharmaceutical ingredients in the composition of analyzed strategically important registered drugs of Ukrainian production (blood and blood forming organs (groups B01, B02, B05 according to the ATC classification), systemic hormonal preparations (groups H01, H02), antiinfectives for systemic use (groups J01, J02, J04)) was revealed in the majority.
Conclusions. The advantage of foreign synthetic active pharmaceutical ingredients with the share of 71.4 % is noted according to the results of registered on market of Ukraine active active pharmaceutical ingredients assortment analysis. Plant trade names (55.8 %), almost half of them (44.4 %) are medicinal plant raw materials, predominate among the domestic active pharmaceutical ingredients. The share of Ukrainian active pharmaceutical ingredients in the composition of studied groups of drugs is extremely small. Taking urgent measures for adjustment and optimization of production of active pharmaceutical ingredients that are components of strategically important groups of drugs, is necessary.
References
Dorovskiy OV, Oliynyk AD. [Pharmaceutical industry of Ukraine: current status and directions of strategic development]. Naukovyi visnyk Khersonskoho derzhavnoho universytetu. Seria: Ekonomichni nauky. 2014;7(4): 75-8. Ukrainian.
State Register of Medicines of Ukraine [Electronic resource]. Available from: http://www.drlz.kiev.ua.
Kostiuk HV, Kovalenko AV. [Competitiveness of the pharmaceutical industry of Ukraine]. Efektyvna ekonomika. 2013; 11. Available from: http://www.economy.nayka.com.ua/?op=1&z=2547. Ukrainian.
Dorovskiy ОV. [World pharmaceutical market: structure, development trends, growth points]. Naukovyi visnyk Khersonskoho derzhavnoho universytetu. Seria: Ekonomichni nauky. 2014;9(1): 34-8. Ukrainian.
Kushniruk VM. [Standardization of industrial synthesis of active pharmaceutical ingredients by the example of amizone and dibamk]. Extended abstract of Candidate’s thesis.15.00.03. Kharkiv; 2017. Ukrainian.
Vitiuk АV, Trachenko КR. [Supplementary Trends in Development of the Pharmaceutical Industry of Ukraine]. Visnyk Vinnytskoho politekhnichnoho instytutu. Seriia: Ekonomika ta menedzhment. 2018;6: 35-43. doi: 10.31649/1997-9266-2018-141-6-35-43. Ukrainian. DOI: https://doi.org/10.31649/1997-9266-2018-141-6-35-43
Some issues of state regulation of prices for medicines and medical devices: resolution of the Cabinet of Ministers of Ukraine March 25, 2009 No. 333. [Electronic resource]. Available from: https://zakon.rada.gov.ua/laws/show/333-2009-%D0%BF#n15.
Downloads
Published
How to Cite
Issue
Section
License
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
